Evidence mapPaperPMID 23786536Full record

Trial reportClinical science (London, England : 1979)2013

Mineralocorticoid receptors modulate vascular endothelial function in human obesity.

Moon-Hyon Hwang, Jeung-Ki Yoo, Meredith Luttrell, Han-Kyul Kim, Thomas H Meade, Mark English, Mark S Segal, Demetra D Christou

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical science (London, England : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. All-Extremity Exercise Training Improves Arterial Stiffness in Older Adults.Medicine and science in sports and exercise · 2017
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Endothelial HSP72 is not reduced in type 2 diabetes nor is it a key determinant of endothelial insulin sensitivity.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  9. Obesity and cardiovascular disease in women.International journal of obesity (2005) · 2020
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. The Role of Aldosterone in Obesity-Related Hypertension.American journal of hypertension · 2016
    Review
  17. Article
  18. Article
  19. Review
  20. Cortisol dysregulation in obesity-related metabolic disorders.Current opinion in endocrinology, diabetes, and obesity · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Moon-Hyon HwangDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA.
Jeung-Ki Yoo
Meredith Luttrell
Han-Kyul Kim
Thomas H Meade
Mark English
Mark S Segal
Demetra D Christou
University of Florida · USBaylor Scott & White Health · USTexas A&M University · USTexas A&M University System · US

Funding

NIA NIH HHS AG 032067NIA NIH HHS R03 AG032067
6 · The paper itself

Abstract

Obesity increases linearly with age and is associated with impaired vascular endothelial function and increased risk of cardiovascular disease. MRs (mineralocorticoid receptors) contribute to impaired vascular endothelial function in cardiovascular disease; however, their role in uncomplicated human obesity is unknown. Because plasma aldosterone levels are elevated in obesity and adipocytes may be a source of aldosterone, we hypothesized that MRs modulate vascular endothelial function in older adults in an adiposity-dependent manner. To test this hypothesis, we administered MR blockade (eplerenone; 100 mg/day) for 1 month in a balanced randomized double-blind placebo-controlled cross-over study to 22 older adults (ten men, 55-79 years) varying widely in adiposity [BMI (body mass index): 20-45 kg/m²], but who were free from overt cardiovascular disease. We evaluated vascular endothelial function [brachial artery FMD (flow-mediated dilation)] via ultrasonography) and oxidative stress (plasma F2-isoprostanes and vascular endothelial cell protein expression of nitrotyrosine and NADPH oxidase p47phox) during placebo and MR blockade. In the whole group, oxidative stress (P>0.05) and FMD did not change with MR blockade (6.39 ± 0.67 compared with 6.23 ± 0.73%; P=0.7). However, individual improvements in FMD in response to eplerenone were associated with higher total body fat (BMI: r=0.45, P=0.02; and dual-energy X-ray absorptiometry-derived percentage body fat: r=0.50, P=0.009) and abdominal fat (total: r=0.61, P=0.005; visceral: r=0.67, P=0.002; and subcutaneous: r=0.48, P=0.03). In addition, greater improvements in FMD with eplerenone were related to higher baseline fasting glucose (r=0.53, P=0.01). MRs influence vascular endothelial function in an adiposity-dependent manner in healthy older adults.

Indexed as

Abdominal FatAgedBody CompositionBody Mass IndexBrachial ArteryCross-Over StudiesDouble-Blind MethodEndothelial CellsEplerenoneF2-IsoprostanesFemaleHumansMaleMiddle AgedMineralocorticoid Receptor AntagonistsNADPH Oxidases3-nitrotyrosineEplerenoneF2-IsoprostanesMineralocorticoid Receptor AntagonistsNADPH OxidasesReceptors, MineralocorticoidSpironolactoneTyrosine

Identifiers

PMID23786536
PMCPMC4312011
OpenAlexW2088660937

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.